Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide for 24 weeks when added to treatment with interferon-beta in subjects with multiple sclerosis https://kusajili.com:443/Trial/NUTRz--udk-KiM3vLEpscQ%24a-randomized-multinational-double-blind-placebo-controlled-parallel-group-design-pilot-study-to-estimate-the-tolerability-safet
I have read and accept the terms of use of the site and the Privacy Policy
Send your message